{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:57:38Z","timestamp":1781139458447,"version":"3.54.1"},"reference-count":238,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the General Program of Basic Scientific Research Project of Liaoning Provincial Department of Education","award":["No. LJKMZ20221177"],"award-info":[{"award-number":["No. LJKMZ20221177"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04385-3","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T16:53:44Z","timestamp":1777049624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Illuminating the path to oncolysis: rise of microbial phototherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Boquan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"4385_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17:119.","journal-title":"J Hematol Oncol"},{"key":"4385_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"A Zafar","year":"2025","unstructured":"Zafar A, Khatoon S, Khan MJ, Abu J, Naeem A. Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Oncol. 2025;16:607.","journal-title":"Discov Oncol"},{"key":"4385_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.7150\/thno.100970","volume":"15","author":"YJ Choi","year":"2025","unstructured":"Choi YJ, Kim MJ, Lee YJ, Choi M, Shim WS, Park M, Kim YC, Kang KW. Prevention of radiotherapy-induced pro-tumorigenic microenvironment by SFK inhibitors. Theranostics. 2025;15:875\u201393.","journal-title":"Theranostics"},{"key":"4385_CR4","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.drup.2021.100777","volume":"58","author":"Z Su","year":"2021","unstructured":"Su Z, Dong S, Zhao SC, Liu K, Tan Y, Jiang X, Assaraf YG, Qin B, Chen ZS, Zou C. Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat. 2021;58:100777.","journal-title":"Drug Resist Updat"},{"key":"4385_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-023-00776-9","volume":"20","author":"MB Lustberg","year":"2023","unstructured":"Lustberg MB, Kuderer NM, Desai A, Bergerot C, Lyman GH. Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship. Nat Rev Clin Oncol. 2023;20:527\u201342.","journal-title":"Nat Rev Clin Oncol"},{"key":"4385_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jconrel.2023.07.015","volume":"360","author":"J Zhou","year":"2023","unstructured":"Zhou J, Cao C, Zhang X, Zhang X, Li J, Deng H, Wang S. Gas-assisted phototherapy for cancer treatment. J Control Release. 2023;360:564\u201377.","journal-title":"J Control Release"},{"key":"4385_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41392-025-02140-y","volume":"10","author":"Y Cai","year":"2025","unstructured":"Cai Y, Chai T, Nguyen W, Liu J, Xiao E, Ran X, Ran Y, Du D, Chen W, Chen X. Phototherapy in cancer treatment: strategies and challenges. Signal Transduct Target Ther. 2025;10:115.","journal-title":"Signal Transduct Target Ther"},{"key":"4385_CR8","doi-asserted-by":"publisher","first-page":"117672","DOI":"10.1016\/j.ejmech.2025.117672","volume":"291","author":"S Ning","year":"2025","unstructured":"Ning S, Yao Y, Feng X, Tian Y. Recent advances in developing bioorthogonally activatable photosensitizers for photodynamic therapy. Eur J Med Chem. 2025;291:117672.","journal-title":"Eur J Med Chem"},{"key":"4385_CR9","doi-asserted-by":"publisher","first-page":"103541","DOI":"10.1016\/j.cis.2025.103541","volume":"342","author":"N Priyadarshi","year":"2025","unstructured":"Priyadarshi N, Kaushal S, Garg P, Sagar P, Gupta R, Kaur J, Kumar A, Kumar S, Singhal NK. Advances in photothermal therapy for cancer and bacterial cells ablation using various nanomaterials. Adv Colloid Interface Sci. 2025;342:103541.","journal-title":"Adv Colloid Interface Sci"},{"key":"4385_CR10","first-page":"100218","volume":"14","author":"AN Al-Jamal","year":"2025","unstructured":"Al-Jamal AN, Al-Hussainy AF, Mohammed BA, Abbas HH, Kadhim IM, Ward ZH, et al. Photodynamic therapy (PDT) in drug delivery: nano-innovations enhancing treatment outcomes. Health Sci Rev. 2025;14:100218.","journal-title":"Health Sci Rev"},{"key":"4385_CR11","first-page":"100775","volume":"18","author":"X Li","year":"2023","unstructured":"Li X, Chen L, Huang M, Zeng S, Zheng J, Peng S, Wang Y, Cheng H, Li S. Innovative strategies for photodynamic therapy against hypoxic tumor. Asian J Pharm Sci. 2023;18:100775.","journal-title":"Asian J Pharm Sci"},{"key":"4385_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/acs.accounts.3c00771","volume":"57","author":"C Zhao","year":"2024","unstructured":"Zhao C, Wang C, Shan W, Wang Z, Chen X, Deng H. Nanomedicines for an enhanced immunogenic cell death-based in situ cancer vaccination response. Acc Chem Res. 2024;57:905\u201318.","journal-title":"Acc Chem Res"},{"key":"4385_CR13","doi-asserted-by":"publisher","first-page":"101563","DOI":"10.1016\/j.mtbio.2025.101563","volume":"31","author":"L Yang","year":"2025","unstructured":"Yang L, Zhang Y, Liu J, Wang X, Zhang L, Wan H. A tumor-targeting black phosphorus-based nanoplatform for controlled chemo-photothermal therapy of breast cancer. Mater Today Bio. 2025;31:101563.","journal-title":"Mater Today Bio"},{"key":"4385_CR14","doi-asserted-by":"publisher","first-page":"101466","DOI":"10.1016\/j.nantod.2022.101466","volume":"44","author":"L Zhou","year":"2022","unstructured":"Zhou L, Feng B, Wang H, Wang D, Li Y. A bispecific nanomodulator to potentiate photothermal cancer immunotherapy. Nano Today. 2022;44:101466.","journal-title":"Nano Today"},{"key":"4385_CR15","doi-asserted-by":"publisher","first-page":"121124","DOI":"10.1016\/j.biomaterials.2021.121124","volume":"277","author":"D Lin","year":"2021","unstructured":"Lin D, Feng X, Mai B, Li X, Wang F, Liu J, Liu X, Zhang K, Wang X. Bacterial-based cancer therapy: An emerging toolbox for targeted drug\/gene delivery. Biomaterials. 2021;277:121124.","journal-title":"Biomaterials"},{"key":"4385_CR16","doi-asserted-by":"publisher","first-page":"114449","DOI":"10.1016\/j.addr.2022.114449","volume":"188","author":"Y Zi","year":"2022","unstructured":"Zi Y, Yang K, He J, Wu Z, Liu J, Zhang W. Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms. Adv Drug Deliv Rev. 2022;188:114449.","journal-title":"Adv Drug Deliv Rev"},{"key":"4385_CR17","doi-asserted-by":"publisher","first-page":"2411070","DOI":"10.1002\/adfm.202411070","volume":"35","author":"Z Wang","year":"2025","unstructured":"Wang Z, Yang Z, Li S, Kwong CHT, Zhang D, Wei J, Gao C, Zhang Q-w, Wang R. Light-Directed Microalgae Micromotor with Supramolecular Backpacks for Photodynamic Therapy. Adv Funct Mater. 2025;35:2411070.","journal-title":"Adv Funct Mater"},{"key":"4385_CR18","doi-asserted-by":"publisher","first-page":"e2313389","DOI":"10.1002\/adma.202313389","volume":"36","author":"J Jia","year":"2024","unstructured":"Jia J, Wang X, Lin X, Zhao Y. Engineered Microorganisms for Advancing Tumor Therapy. Adv Mater. 2024;36:e2313389.","journal-title":"Adv Mater"},{"key":"4385_CR19","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1016\/j.ymthe.2025.07.034","volume":"33","author":"K Vazquez-Arreguin","year":"2025","unstructured":"Vazquez-Arreguin K, Rivera-Caraballo KA, Ventarapragada D, Chiocca EA, Kaur B. Oncolytic HSV and cancer drug interactions: current clinical status and future directions. Mol Ther. 2025;33:4748\u201365.","journal-title":"Mol Ther"},{"key":"4385_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12951-024-02793-x","volume":"22","author":"S Xiao","year":"2024","unstructured":"Xiao S, Mu M, Feng C, Pan S, Chen N. The application of bacteria-nanomaterial hybrids in antitumor therapy. J Nanobiotechnol. 2024;22:536.","journal-title":"J Nanobiotechnol"},{"key":"4385_CR21","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.ymthe.2024.05.014","volume":"32","author":"JJ Rojas","year":"2024","unstructured":"Rojas JJ, Van Hoecke L, Conesa M, Bueno-Merino C, Del Canizo A, Riederer S, Barcia M, Brosinski K, Lehmann MH, Volz A, et al. A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses. Mol Ther. 2024;32:2406\u201322.","journal-title":"Mol Ther"},{"key":"4385_CR22","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1016\/j.apsb.2023.08.028","volume":"13","author":"L Guo","year":"2023","unstructured":"Guo L, Ding J, Zhou W. Converting bacteria into autologous tumor vaccine via surface biomineralization of calcium carbonate for enhanced immunotherapy. Acta Pharm Sin B. 2023;13:5074\u201390.","journal-title":"Acta Pharm Sin B"},{"key":"4385_CR23","doi-asserted-by":"publisher","first-page":"114364","DOI":"10.1016\/j.addr.2022.114364","volume":"187","author":"H Shen","year":"2022","unstructured":"Shen H, Aggarwal N, Wun KS, Lee YS, Hwang IY, Chang MW. Engineered microbial systems for advanced drug delivery. Adv Drug Deliv Rev. 2022;187:114364.","journal-title":"Adv Drug Deliv Rev"},{"key":"4385_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2217\/nnm-2022-0257","volume":"18","author":"P Gawali","year":"2023","unstructured":"Gawali P, Saraswat A, Bhide S, Gupta S, Patel K. Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a \u2018golden gate\u2019 for nanomedicine in preclinical studies? Nanomed (Lond). 2023;18:169\u201390.","journal-title":"Nanomed (Lond)"},{"key":"4385_CR25","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1039\/D3MH00717K","volume":"10","author":"SK Filippov","year":"2023","unstructured":"Filippov SK, Khusnutdinov R, Murmiliuk A, Inam W, Zakharova LY, Zhang H, Khutoryanskiy VV. Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results. Mater Horiz. 2023;10:5354\u201370.","journal-title":"Mater Horiz"},{"key":"4385_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/v15020330","author":"G Saint-Pierre Contreras","year":"2023","unstructured":"Saint-Pierre Contreras G, Conei Valencia D, Lizama L, Vargas Zuniga D, Avendano Carvajal LF, Ampuero Llanos S. An old acquaintance: could adenoviruses be our next pandemic threat? Viruses. 2023. https:\/\/doi.org\/10.3390\/v15020330.","journal-title":"Viruses"},{"key":"4385_CR27","doi-asserted-by":"publisher","first-page":"e2100507","DOI":"10.1002\/mabi.202100507","volume":"22","author":"B Thongrom","year":"2022","unstructured":"Thongrom B, Sharma A, Nie C, Quaas E, Raue M, Bhatia S, Haag R. Scaffold Flexibility Controls Binding of Herpes Simplex Virus Type 1 with Sulfated Dendritic Polyglycerol Hydrogels Fabricated by Thiol-Maleimide Click Reaction. Macromol Biosci. 2022;22:e2100507.","journal-title":"Macromol Biosci"},{"key":"4385_CR28","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1039\/D3BM01095C","volume":"11","author":"M Zhou","year":"2023","unstructured":"Zhou M, Yin Y, Zhao J, Zhou M, Bai Y, Zhang P. Applications of microalga-powered microrobots in targeted drug delivery. Biomater Sci. 2023;11:7512\u201330.","journal-title":"Biomater Sci"},{"key":"4385_CR29","doi-asserted-by":"publisher","first-page":"115519","DOI":"10.1016\/j.addr.2025.115519","volume":"219","author":"R Wang","year":"2025","unstructured":"Wang R, Wang Z, Zhang M, Zhong D, Zhou M. Application of photosensitive microalgae in targeted tumor therapy. Adv Drug Deliv Rev. 2025;219:115519.","journal-title":"Adv Drug Deliv Rev"},{"key":"4385_CR30","doi-asserted-by":"publisher","first-page":"215830","DOI":"10.1016\/j.canlet.2022.215830","volume":"545","author":"M Zhan","year":"2022","unstructured":"Zhan M, Zhang Z, Zhao X, Zhang Y, Liu T, Lu L, Li XY. CD155 in tumor progression and targeted therapy. Cancer Lett. 2022;545:215830.","journal-title":"Cancer Lett"},{"key":"4385_CR31","doi-asserted-by":"publisher","first-page":"e728","DOI":"10.1038\/cddis.2013.259","volume":"4","author":"JS Carew","year":"2013","unstructured":"Carew JS, Espitia CM, Zhao W, Kelly KR, Coffey M, Freeman JW, Nawrocki ST. Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer. Cell Death Dis. 2013;4:e728.","journal-title":"Cell Death Dis"},{"key":"4385_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.immuni.2022.12.010","volume":"56","author":"D Briukhovetska","year":"2023","unstructured":"Briukhovetska D, Suarez-Gosalvez J, Voigt C, Markota A, Giannou AD, Schubel M, Jobst J, Zhang T, Dorr J, Markl F, et al. T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis. Immunity. 2023;56:143\u2013e161111.","journal-title":"Immunity"},{"key":"4385_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051099","author":"BH Lee","year":"2022","unstructured":"Lee BH, Kim JH, Kang KW, Lee SR, Park Y, Sung HJ, et al. PVR (CD155) expression as a potential prognostic marker in multiple myeloma. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10051099.","journal-title":"Biomedicines"},{"key":"4385_CR34","doi-asserted-by":"publisher","first-page":"118296","DOI":"10.1016\/j.lfs.2020.118296","volume":"261","author":"M Drozdz","year":"2020","unstructured":"Drozdz M, Makuch S, Cieniuch G, Wozniak M, Ziolkowski P. Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications. Life Sci. 2020;261:118296.","journal-title":"Life Sci"},{"key":"4385_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fonc.2020.00179","volume":"10","author":"SP Walker","year":"2020","unstructured":"Walker SP, Tangney M, Claesson MJ. Sequence-Based Characterization of Intratumoral Bacteria-A Guide to Best Practice. Front Oncol. 2020;10:179.","journal-title":"Front Oncol"},{"key":"4385_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/v13091677","author":"I Appolloni","year":"2021","unstructured":"Appolloni I, Alessandrini F, Menotti L, Avitabile E, Marubbi D, Piga N, et al. Specificity, safety, efficacy of EGFRvIII-retargeted oncolytic HSV for xenotransplanted human glioblastoma. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13091677.","journal-title":"Viruses"},{"key":"4385_CR37","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.7150\/thno.16135","volume":"6","author":"SH Park","year":"2016","unstructured":"Park SH, Zheng JH, Nguyen VH, Jiang SN, Kim DY, Szardenings M, et al. RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated Salmonella-mediated cancer therapy. Theranostics. 2016;6:1672\u201382.","journal-title":"Theranostics"},{"key":"4385_CR38","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1039\/D3SC05539F","volume":"15","author":"M Ahmadi","year":"2024","unstructured":"Ahmadi M, Ritter CA, von Woedtke T, Bekeschus S, Wende K. Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis. Chem Sci. 2024;15:1966\u20132006.","journal-title":"Chem Sci"},{"key":"4385_CR39","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1021\/acsnano.3c00041","volume":"17","author":"C Gao","year":"2023","unstructured":"Gao C, Kwong CHT, Wang Q, Kam H, Xie B, Lee SM, et al. Conjugation of macrophage-mimetic microalgae and liposome for antitumor sonodynamic immunotherapy via hypoxia alleviation and autophagy inhibition. ACS Nano. 2023;17:4034\u201349.","journal-title":"ACS Nano"},{"key":"4385_CR40","doi-asserted-by":"publisher","first-page":"0034","DOI":"10.34133\/bmr.0034","volume":"28","author":"Z Chen","year":"2024","unstructured":"Chen Z, Li Y, Xiang Q, Wu Y, Ran H, Cao Y. Metallic Copper-Based Dual-Enzyme Biomimetic Nanoplatform for Mild Photothermal Enhancement of Anticancer Catalytic Activity. Biomater Res. 2024;28:0034.","journal-title":"Biomater Res"},{"key":"4385_CR41","doi-asserted-by":"publisher","first-page":"34615","DOI":"10.1021\/acsnano.4c09387","volume":"18","author":"D Liu","year":"2024","unstructured":"Liu D, Lu N, Zang F, Lu M, Zhang J, Zhao Y, Wan H, Wang M, Li QQ, Wang F, et al. Magnetic Resonance Imaging-Based Radiogenomic Analysis Reveals Genomic Determinants for Nanoparticle Delivery into Tumors. ACS Nano. 2024;18:34615\u201329.","journal-title":"ACS Nano"},{"key":"4385_CR42","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1038\/s41467-025-65477-6","volume":"16","author":"M Mardamshina","year":"2025","unstructured":"Mardamshina M, Karagach S, Mohan V, Arad G, Necula D, Golani O, Fellus-Alyagor L, Shenoy A, Krol K, Pirak D, et al. Integrated spatial proteomic analysis of breast cancer heterogeneity unravels cancer cell phenotypic plasticity. Nat Commun. 2025;16:10482.","journal-title":"Nat Commun"},{"key":"4385_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","volume":"21","author":"A Emami Nejad","year":"2021","unstructured":"Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M, et al. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int. 2021;21:62.","journal-title":"Cancer Cell Int"},{"key":"4385_CR44","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41564-023-01405-y","volume":"8","author":"A Rybak-Wolf","year":"2023","unstructured":"Rybak-Wolf A, Wyler E, Pentimalli TM, Legnini I, Oliveras Martinez A, Glazar P, Loewa A, Kim SJ, Kaufer BB, Woehler A, et al. Modelling viral encephalitis caused by herpes simplex virus 1 infection in cerebral organoids. Nat Microbiol. 2023;8:1252\u201366.","journal-title":"Nat Microbiol"},{"key":"4385_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41579-024-01105-2","volume":"23","author":"CL Holmes","year":"2025","unstructured":"Holmes CL, Albin OR, Mobley HLT, Bachman MA. Bloodstream infections: mechanisms of pathogenesis and opportunities for intervention. Nat Rev Microbiol. 2025;23:210\u201324.","journal-title":"Nat Rev Microbiol"},{"key":"4385_CR46","doi-asserted-by":"publisher","first-page":"44541","DOI":"10.1021\/acsami.0c14400","volume":"12","author":"W Li","year":"2020","unstructured":"Li W, Zhong D, Hua S, Du Z, Zhou M. Biomineralized biohybrid algae for tumor hypoxia modulation and cascade radio-photodynamic therapy. ACS Appl Mater Interfaces. 2020;12:44541\u201353.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4385_CR47","doi-asserted-by":"publisher","unstructured":"Ripa I, Andreu S, Lopez-Guerrero JA, Bello-Morales R. Interplay between autophagy and herpes simplex virus type 1: ICP34.5, one of the main actors. Int J Mol Sci. 2022;23:13643. https:\/\/doi.org\/10.3390\/ijms232113643.","DOI":"10.3390\/ijms232113643"},{"key":"4385_CR48","doi-asserted-by":"publisher","first-page":"e28108","DOI":"10.1002\/jmv.28108","volume":"95","author":"Y Shen","year":"2023","unstructured":"Shen Y, Song W, Lin D, Zhang X, Wang M, Li Y, Yang Z, Guo S, Wang Z, Sheng J, et al. VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes. J Med Virol. 2023;95:e28108.","journal-title":"J Med Virol"},{"key":"4385_CR49","doi-asserted-by":"publisher","first-page":"8878","DOI":"10.1021\/ja0485659","volume":"126","author":"JA Read","year":"2004","unstructured":"Read JA, Ahmed RA, Morrison JP, Coleman WG Jr., Tanner ME. The mechanism of the reaction catalyzed by ADP-beta-L-glycero-D-manno-heptose 6-epimerase. J Am Chem Soc. 2004;126:8878\u20139.","journal-title":"J Am Chem Soc"},{"key":"4385_CR50","doi-asserted-by":"publisher","unstructured":"Frahm M, Felgner S, Kocijancic D, Rohde M, Hensel M, Curtiss R 3rd, et al. Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy. mBio. 2015. https:\/\/doi.org\/10.1128\/mBio.00254-15.","DOI":"10.1128\/mBio.00254-15"},{"key":"4385_CR51","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1158\/0008-5472.CAN-04-3227","volume":"65","author":"H Kambara","year":"2005","unstructured":"Kambara H, Okano H, Chiocca EA, Saeki Y. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor. Cancer Res. 2005;65:2832\u20139.","journal-title":"Cancer Res"},{"key":"4385_CR52","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1073\/pnas.101136398","volume":"98","author":"T Todo","year":"2001","unstructured":"Todo T, Martuza RL, Rabkin SD, Johnson PA. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc Natl Acad Sci U S A. 2001;98:6396\u2013401.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4385_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.molimm.2019.03.003","volume":"111","author":"G Aldapa-Vega","year":"2019","unstructured":"Aldapa-Vega G, Moreno-Eutimio MA, Berlanga-Taylor AJ, Jimenez-Uribe AP, Nieto-Velazquez G, Lopez-Ortega O, Mancilla-Herrera I, Cortes-Malagon EM, Gunn JS, Isibasi A, et al. Structural variants of Salmonella Typhimurium lipopolysaccharide induce less dimerization of TLR4\/MD-2 and reduced pro-inflammatory cytokine production in human monocytes. Mol Immunol. 2019;111:43\u201352.","journal-title":"Mol Immunol"},{"key":"4385_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","volume":"623","author":"AL Ling","year":"2023","unstructured":"Ling AL, Solomon IH, Landivar AM, Nakashima H, Woods JK, Santos A, Masud N, Fell G, Mo X, Yilmaz AS, et al. Clinical trial links oncolytic immunoactivation to survival in glioblastoma. Nature. 2023;623:157\u201366.","journal-title":"Nature"},{"key":"4385_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41522-024-00479-8","volume":"10","author":"T Zhou","year":"2024","unstructured":"Zhou T, Wu J, Tang H, Liu D, Jeon BH, Jin W, Wang Y, Zheng Y, Khan A, Han H, Li X. Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer. NPJ Biofilms Microbiomes. 2024;10:6.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4385_CR56","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1038\/s41401-024-01349-x","volume":"45","author":"ZM Wang","year":"2024","unstructured":"Wang ZM, Li MK, Yang QL, Duan SX, Lou XY, Yang XY, Liu Y, Zhong YW, Qiao Y, Wang ZS, et al. Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells. Acta Pharmacol Sin. 2024;45:2646\u201356.","journal-title":"Acta Pharmacol Sin"},{"key":"4385_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.omto.2022.05.004","volume":"25","author":"V Jawalagatti","year":"2022","unstructured":"Jawalagatti V, Kirthika P, Lee JH. Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium. Mol Ther Oncolytics. 2022;25:350\u201363.","journal-title":"Mol Ther Oncolytics"},{"key":"4385_CR58","doi-asserted-by":"publisher","first-page":"121647","DOI":"10.1016\/j.carbpol.2023.121647","volume":"327","author":"L Gong","year":"2024","unstructured":"Gong L, Zhu J, Yang Y, Qiao S, Ma L, Wang H, Zhang Y. Effect of polyethylene glycol on polysaccharides: From molecular modification, composite matrixes, synergetic properties to embeddable application in food fields. Carbohydr Polym. 2024;327:121647.","journal-title":"Carbohydr Polym"},{"key":"4385_CR59","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1021\/acsapm.1c01760","volume":"4","author":"W Tang","year":"2022","unstructured":"Tang W, Ma W, Meng T, Han W, Liu C, Duan X. Chemically enhanced live probiotic for in vivo tumor targeting and inhibition. ACS Appl Polym Mater. 2022;4:1368\u201376.","journal-title":"ACS Appl Polym Mater"},{"key":"4385_CR60","doi-asserted-by":"publisher","first-page":"e2313953","DOI":"10.1002\/adma.202313953","volume":"36","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Li Q, Wu Y, Zhang W, Ding L, Ji C, Li P, Chen T, Feng L, Tang BZ, Huang X. Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy. Adv Mater. 2024;36:e2313953.","journal-title":"Adv Mater"},{"key":"4385_CR61","doi-asserted-by":"publisher","first-page":"e2206948","DOI":"10.1002\/smll.202206948","volume":"19","author":"S Duan","year":"2023","unstructured":"Duan S, Wang S, Qiao L, Yu X, Wang N, Chen L, Zhang X, Zhao X, Liu H, Wang T, et al. Oncolytic Virus-Driven Biotherapies from Bench to Bedside. Small. 2023;19:e2206948.","journal-title":"Small"},{"key":"4385_CR62","doi-asserted-by":"publisher","first-page":"100515","DOI":"10.1016\/j.mtbio.2022.100515","volume":"18","author":"P Ji","year":"2023","unstructured":"Ji P, An B, Jie Z, Wang L, Qiu S, Ge C, Wu Q, Shi J, Huo M. Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy. Mater Today Bio. 2023;18:100515.","journal-title":"Mater Today Bio"},{"key":"4385_CR63","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gendis.2021.11.011","volume":"10","author":"M Javanbakht","year":"2023","unstructured":"Javanbakht M, Tahmasebzadeh S, Cegolon L, Gholami N, Kashaki M, Nikoueinejad H, Mozafari M, Mozaffari M, Zhao S, Khafaei M, et al. Oncolytic viruses: A novel treatment strategy for breast cancer. Genes Dis. 2023;10:430\u201346.","journal-title":"Genes Dis"},{"key":"4385_CR64","doi-asserted-by":"publisher","first-page":"189110","DOI":"10.1016\/j.bbcan.2024.189110","volume":"1879","author":"S Chattopadhyay","year":"2024","unstructured":"Chattopadhyay S, Hazra R, Mallick A, Gayen S, Roy S. A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment. Biochim Biophys Acta Rev Cancer. 2024;1879:189110.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4385_CR65","doi-asserted-by":"publisher","first-page":"12194","DOI":"10.1021\/acsnano.4c00413","volume":"18","author":"L Lei","year":"2024","unstructured":"Lei L, Yan J, Xin K, Li L, Sun Q, Wang Y, et al. Engineered bacteriophage-based in situ vaccine remodels a tumor microenvironment and elicits potent antitumor immunity. ACS Nano. 2024;18:12194\u2013209.","journal-title":"ACS Nano"},{"key":"4385_CR66","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.2147\/IJN.S368763","volume":"17","author":"H Cui","year":"2022","unstructured":"Cui H, Su Y, Wei W, Xu F, Gao J, Zhang W. How microalgae is effective in oxygen deficiency aggravated diseases? A comprehensive review of literature. Int J Nanomed. 2022;17:3101\u201322.","journal-title":"Int J Nanomed"},{"key":"4385_CR67","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12274-020-3094-0","volume":"14","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu H, Dai X, Li H, Zhou X, Chen S, Zhang J, Liang X-J, Li Z. Cyanobacteria-based near-infrared light-excited self-supplying oxygen system for enhanced photodynamic therapy of hypoxic tumors. Nano Res. 2021;14:667\u201373.","journal-title":"Nano Res"},{"key":"4385_CR68","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12951-024-02654-7","volume":"22","author":"S Hua","year":"2024","unstructured":"Hua S, Zhao J, Li L, Liu C, Zhou L, Li K, Huang Q, Zhou M, Wang K. Photosynthetic bacteria-based whole-cell inorganic-biohybrid system for multimodal enhanced tumor radiotherapy. J Nanobiotechnol. 2024;22:379.","journal-title":"J Nanobiotechnol"},{"key":"4385_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade5111","volume":"9","author":"J-S Cheu","year":"2023","unstructured":"Cheu J-S, Chiu D-C, Kwan K-L, Yang C, Yuen V-H, Goh CC, et al. Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development. Sci Adv. 2023;9:eade5111. https:\/\/doi.org\/10.1126\/sciadv.ade5111.","journal-title":"Sci Adv"},{"key":"4385_CR70","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.semcancer.2021.07.007","volume":"86","author":"PC Sharma","year":"2022","unstructured":"Sharma PC, Sharma D, Sharma A, Bhagat M, Ola M, Thakur VK, Bhardwaj JK, Goyal RK. Recent advances in microbial toxin-related strategies to combat cancer. Semin Cancer Biol. 2022;86:753\u201368.","journal-title":"Semin Cancer Biol"},{"key":"4385_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40487-021-00177-x","volume":"10","author":"F Rommasi","year":"2022","unstructured":"Rommasi F. Bacterial-based methods for cancer treatment: what we know and where we are. Oncol Ther. 2022;10:23\u201354.","journal-title":"Oncol Ther"},{"key":"4385_CR72","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","volume":"21","author":"SY Kwon","year":"2024","unstructured":"Kwon SY, Thi-Thu Ngo H, Son J, Hong Y, Min JJ. Exploiting bacteria for cancer immunotherapy. Nat Rev Clin Oncol. 2024;21:569\u201389.","journal-title":"Nat Rev Clin Oncol"},{"key":"4385_CR73","doi-asserted-by":"publisher","first-page":"8735","DOI":"10.1021\/acs.nanolett.2c03608","volume":"22","author":"JW Wang","year":"2022","unstructured":"Wang JW, Chen QW, Luo GF, Ji P, Han ZY, Song WF, et al. Interference of glucose bioavailability of tumor by engineered biohybrids for potentiating targeting and uptake of antitumor nanodrugs. Nano Lett. 2022;22:8735\u201343.","journal-title":"Nano Lett"},{"key":"4385_CR74","doi-asserted-by":"publisher","first-page":"eadm9561","DOI":"10.1126\/sciadv.adm9561","volume":"10","author":"Y Fan","year":"2024","unstructured":"Fan Y, Ye J, Kang Y, Niu G, Shi J, Yuan X, Li R, Han J, Ji X. Biomimetic piezoelectric nanomaterial-modified oral microrobots for targeted catalytic and immunotherapy of colorectal cancer. Sci Adv. 2024;10:eadm9561.","journal-title":"Sci Adv"},{"key":"4385_CR75","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1021\/acsmaterialslett.3c00749","volume":"5","author":"S-M Zhang","year":"2023","unstructured":"Zhang S-M, Jin X-K, Luo G-F, Liang J-L, Wang Y-Z, Wang J-W, et al. An engineered bacterium-based lactate bioconsumer for regulating immunosuppressive tumor microenvironment to potentiate antitumor immunity. ACS Mater Lett. 2023;5:2785\u201398.","journal-title":"ACS Mater Lett"},{"key":"4385_CR76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-023-10129-8","volume":"43","author":"SF Jawad","year":"2024","unstructured":"Jawad SF, Altalbawy FMA, Hussein RM, Fadhil AA, Jawad MA, Zabibah RS, Taraki TY, Mohan CD, Rangappa KS. The strict regulation of HIF-1\u03b1 by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies. Cancer Metastasis Rev. 2024;43:5\u201327.","journal-title":"Cancer Metastasis Rev"},{"key":"4385_CR77","doi-asserted-by":"publisher","first-page":"117550","DOI":"10.1016\/j.lfs.2020.117550","volume":"250","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj B, Priya LB, Mahalakshmi B, Subbiah S, Hu RM, Velmurugan BK, Baskaran R. Bacterial and viral vectors as vaccine delivery vehicles for breast cancer therapy. Life Sci. 2020;250:117550.","journal-title":"Life Sci"},{"key":"4385_CR78","doi-asserted-by":"publisher","first-page":"102027","DOI":"10.1016\/j.omtn.2023.09.004","volume":"34","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang H, An Y, Chen Z. Construction and application of adenoviral vectors. Mol Ther Nucleic Acids. 2023;34:102027.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4385_CR79","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.tips.2025.02.006","volume":"46","author":"Y Shen","year":"2025","unstructured":"Shen Y, Zhang H, Xue M, Zheng C, Chen Q. Hsv-1 as a gene delivery platform for cancer gene therapy. Trends Pharmacol Sci. 2025;46:324\u201336.","journal-title":"Trends Pharmacol Sci"},{"key":"4385_CR80","doi-asserted-by":"publisher","first-page":"e21487","DOI":"10.1096\/fj.202002539R","volume":"35","author":"A Chongchai","year":"2021","unstructured":"Chongchai A, Waramit S, Suwan K, Al-Bahrani M, Udomruk S, Phitak T, Kongtawelert P, Pothacharoen P, Hajitou A. Bacteriophage-mediated therapy of chondrosarcoma by selective delivery of the tumor necrosis factor alpha (TNF\u03b1) gene. Faseb j. 2021;35:e21487.","journal-title":"Faseb j"},{"key":"4385_CR81","doi-asserted-by":"publisher","first-page":"e2105086","DOI":"10.1002\/advs.202105086","volume":"9","author":"W Qin","year":"2022","unstructured":"Qin W, Xu W, Wang L, Ren D, Cheng Y, Song W, Jiang T, Ma L, Zhang C. Bacteria-Elicited Specific Thrombosis Utilizing Acid-Induced Cytolysin A Expression to Enable Potent Tumor Therapy. Adv Sci (Weinh). 2022;9:e2105086.","journal-title":"Adv Sci (Weinh)"},{"key":"4385_CR82","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41587-020-00745-y","volume":"39","author":"PLH Vo","year":"2021","unstructured":"Vo PLH, Ronda C, Klompe SE, Chen EE, Acree C, Wang HH, et al. CRISPR rna-guided integrases for high-efficiency, multiplexed bacterial genome engineering. Nat Biotechnol. 2021;39:480\u20139.","journal-title":"Nat Biotechnol"},{"key":"4385_CR83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.colsurfb.2018.11.008","volume":"174","author":"E Alemzadeh","year":"2019","unstructured":"Alemzadeh E, Dehshahri A, Dehghanian AR, Afsharifar A, Behjatnia AA, Izadpanah K, Ahmadi F. Enhanced anti-tumor efficacy and reduced cardiotoxicity of doxorubicin delivered in a novel plant virus nanoparticle. Colloids Surf B Biointerfaces. 2019;174:80\u20136.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4385_CR84","doi-asserted-by":"publisher","first-page":"e2304136","DOI":"10.1002\/adhm.202304136","volume":"13","author":"LY Ye","year":"2024","unstructured":"Ye LY, Li YS, Ge T, Liu LC, Si JX, Yang X, Fan WJ, Liu XZ, Zhang YN, Wang JW, et al. Engineered Luminescent Oncolytic Vaccinia Virus Activation of Photodynamic-Immune Combination Therapy for Colorectal Cancer. Adv Healthc Mater. 2024;13:e2304136.","journal-title":"Adv Healthc Mater"},{"key":"4385_CR85","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12951-025-03290-5","volume":"23","author":"K Wang","year":"2025","unstructured":"Wang K, Zhong D, Yang L, Zeng C, Hu Q, Zhou M, Tang Z. Microalgae-based biodegradable embolic agent for the treatment of hepatocellular carcinoma through transarterial embolization. J Nanobiotechnol. 2025;23:234.","journal-title":"J Nanobiotechnol"},{"key":"4385_CR86","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.1002\/anie.201604067","volume":"55","author":"RE Kelemen","year":"2016","unstructured":"Kelemen RE, Mukherjee R, Cao X, Erickson SB, Zheng Y, Chatterjee A. A precise chemical strategy to alter the receptor specificity of the adeno-associated virus. Angew Chem Int Ed Engl. 2016;55:10645\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4385_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102490","author":"R Zong","year":"2023","unstructured":"Zong R, Ruan H, Liu C, Fan S, Li J. Bacteria and bacterial components as natural bio-nanocarriers for drug and gene delivery systems in cancer therapy. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15102490.","journal-title":"Pharmaceutics"},{"key":"4385_CR88","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41378-024-00743-z","volume":"10","author":"A Gholami","year":"2024","unstructured":"Gholami A, Mohkam M, Soleimanian S, Sadraeian M, Lauto A. Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy. Microsyst Nanoeng. 2024;10:113.","journal-title":"Microsyst Nanoeng"},{"key":"4385_CR89","doi-asserted-by":"publisher","first-page":"e202208422","DOI":"10.1002\/anie.202208422","volume":"61","author":"B Chu","year":"2022","unstructured":"Chu B, Yang Y, Tang J, Song B, He Y, Wang H. Trojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues. Angew Chem Int Ed Engl. 2022;61:e202208422.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4385_CR90","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1021\/acsami.3c16995","volume":"16","author":"X An","year":"2024","unstructured":"An X, Zhong D, Wu W, Wang R, Yang L, Jiang Q, et al. Doxorubicin-loaded microalgal delivery system for combined chemotherapy and enhanced photodynamic therapy of osteosarcoma. ACS Appl Mater Interfaces. 2024;16:6868\u201378.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4385_CR91","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s13346-023-01362-3","volume":"13","author":"DM Dogbey","year":"2023","unstructured":"Dogbey DM, Torres VES, Fajemisin E, Mpondo L, Ngwenya T, Akinrinmade OA, et al. Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy. Drug Deliv Transl Res. 2023;13:2719\u201338.","journal-title":"Drug Deliv Transl Res"},{"key":"4385_CR92","doi-asserted-by":"publisher","first-page":"108557","DOI":"10.1016\/j.cclet.2023.108557","volume":"35","author":"L Guo","year":"2024","unstructured":"Guo L, Ding J, Zhou W. Harnessing bacteria for tumor therapy: Current advances and challenges. Chin Chem Lett. 2024;35:108557.","journal-title":"Chin Chem Lett"},{"key":"4385_CR93","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2023.06.009","volume":"360","author":"H Lu","year":"2023","unstructured":"Lu H, Niu L, Yu L, Jin K, Zhang J, Liu J, Zhu X, Wu Y, Zhang Y. Cancer phototherapy with nano-bacteria biohybrids. J Control Release. 2023;360:133\u201348.","journal-title":"J Control Release"},{"key":"4385_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6010012","author":"F Borgia","year":"2018","unstructured":"Borgia F, Giuffrida R, Caradonna E, Vaccaro M, Guarneri F, Cannav\u00f2 SP. Early and late onset side effects of photodynamic therapy. Biomedicines. 2018. https:\/\/doi.org\/10.3390\/biomedicines6010012.","journal-title":"Biomedicines"},{"key":"4385_CR95","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jconrel.2022.09.050","volume":"351","author":"Y Guo","year":"2022","unstructured":"Guo Y, Song M, Liu X, Chen Y, Xun Z, Sun Y, et al. Photodynamic therapy-improved oncolytic bacterial immunotherapy with FAP-encoding S. typhimurium. J Control Release. 2022;351:860\u201371.","journal-title":"J Control Release"},{"key":"4385_CR96","doi-asserted-by":"publisher","first-page":"e2306480","DOI":"10.1002\/advs.202306480","volume":"11","author":"H Jiang","year":"2024","unstructured":"Jiang H, Cao Z, Liu Y, Liu R, Zhou Y, Liu J. Bacteria-Based Living Probes: Preparation and the Applications in Bioimaging and Diagnosis. Adv Sci (Weinh). 2024;11:e2306480.","journal-title":"Adv Sci (Weinh)"},{"key":"4385_CR97","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/IJN.S500314","volume":"20","author":"Y Jiang","year":"2025","unstructured":"Jiang Y. Photosynthetic bacteria: light-responsive biomaterials for anti-tumor photodynamic therapy. Int J Nanomed. 2025;20:465\u201382.","journal-title":"Int J Nanomed"},{"key":"4385_CR98","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1515\/nanoph-2021-0209","volume":"10","author":"J Zou","year":"2021","unstructured":"Zou J, Li L, Yang Z, Chen X. Phototherapy meets immunotherapy: a win\u2013win strategy to fight against cancer. Nanophotonics. 2021;10:3229\u201345. https:\/\/doi.org\/10.1515\/nanoph-2021-0209.","journal-title":"Nanophotonics"},{"key":"4385_CR99","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.7150\/thno.81718","volume":"13","author":"C Yin","year":"2023","unstructured":"Yin C, Wang Z, Dai C, Yang B, Wang W, Yang E, Guo F, Fan C, Zhang P, Sun J, Sun D. Light-triggered photosynthetic engineered bacteria for enhanced-photodynamic therapy by relieving tumor hypoxic microenvironment. Theranostics. 2023;13:1632\u201348.","journal-title":"Theranostics"},{"key":"4385_CR100","doi-asserted-by":"publisher","first-page":"e2305764","DOI":"10.1002\/smll.202305764","volume":"20","author":"W Song","year":"2024","unstructured":"Song W, He Y, Feng Y, Wang Y, Li X, Wu Y, Zhang S, Zhong L, Yan F, Sun L. Image-Guided Photothermal and Immune Therapy of Tumors via Melanin-Producing Genetically Engineered Bacteria. Small. 2024;20:e2305764.","journal-title":"Small"},{"key":"4385_CR101","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.2147\/IJN.S289310","volume":"16","author":"J Shao","year":"2021","unstructured":"Shao J, Liang R, Ding D, Zheng X, Zhu X, Hu S, et al. A smart multifunctional nanoparticle for enhanced near-infrared image-guided photothermal therapy against gastric cancer. Int J Nanomed. 2021;16:2897\u2013915.","journal-title":"Int J Nanomed"},{"key":"4385_CR102","doi-asserted-by":"publisher","first-page":"137652","DOI":"10.1016\/j.jcis.2025.137652","volume":"693","author":"S Gan","year":"2025","unstructured":"Gan S, Wen X, Li L, Ao K, Qin J, Hao Y, Guo X. A cancer theranostic nanoplatform for second near-infrared fluorescence imaging-guided carbon monoxide-sensitized mild photothermal therapy with ICD induction. J Colloid Interface Sci. 2025;693:137652.","journal-title":"J Colloid Interface Sci"},{"key":"4385_CR103","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2024.09.006","volume":"375","author":"Z Qi","year":"2024","unstructured":"Qi Z, Gu J, Qu L, Shi X, He Z, Sun J, et al. Advancements of engineered live oncolytic biotherapeutics (microbe\/virus\/cells): preclinical research and clinical progress. J Control Release. 2024;375:209\u201335.","journal-title":"J Control Release"},{"key":"4385_CR104","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1038\/s41467-024-49156-6","volume":"15","author":"KF Xu","year":"2024","unstructured":"Xu KF, Wu SY, Wang Z, Guo Y, Zhu YX, Li C, Shan BH, Zhang X, Liu X, Wu FG. Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic photothermal immunotherapy. Nat Commun. 2024;15:5147.","journal-title":"Nat Commun"},{"key":"4385_CR105","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41467-022-32837-5","volume":"13","author":"R Sun","year":"2022","unstructured":"Sun R, Liu M, Lu J, Chu B, Yang Y, Song B, Wang H, He Y. Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy. Nat Commun. 2022;13:5127.","journal-title":"Nat Commun"},{"key":"4385_CR106","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1038\/s41467-019-12088-7","volume":"10","author":"J Tang","year":"2019","unstructured":"Tang J, Chu B, Wang J, Song B, Su Y, Wang H, He Y. Multifunctional nanoagents for ultrasensitive imaging and photoactive killing of Gram-negative and Gram-positive bacteria. Nat Commun. 2019;10:4057.","journal-title":"Nat Commun"},{"key":"4385_CR107","doi-asserted-by":"publisher","first-page":"e2308506","DOI":"10.1002\/advs.202308506","volume":"11","author":"M Chen","year":"2024","unstructured":"Chen M, Guo B, Cheng H, Wang W, Jin J, Zhang Y, Deng X, Yang W, Wu C, Gao X, et al. Genetic Engineering Bacillus thuringiensis Enable Melanin Biosynthesis for Anti-Tumor and Anti-Inflammation. Adv Sci (Weinh). 2024;11:e2308506.","journal-title":"Adv Sci (Weinh)"},{"key":"4385_CR108","doi-asserted-by":"publisher","first-page":"159770","DOI":"10.1016\/j.cej.2025.159770","volume":"505","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Kasala D, Jiao A, Lee S-H, Hong J, Kim Y, Yoon AR, Yun C-O. Potent antitumor effect of intranasally administrable pH-sensitive and photothermal polymeric oncolytic adenovirus for the treatment of brain cancer. Chem Eng J. 2025;505:159770.","journal-title":"Chem Eng J"},{"key":"4385_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030597","author":"T Thambi","year":"2022","unstructured":"Thambi T, Lee J, Yoon AR, Kasala D, Yun C-O. A pH- and bioreducible cationic copolymer with amino acids and piperazines for adenovirus delivery. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14030597.","journal-title":"Pharmaceutics"},{"key":"4385_CR110","doi-asserted-by":"publisher","first-page":"25322","DOI":"10.1021\/acsnano.3c08752","volume":"17","author":"Z Teng","year":"2023","unstructured":"Teng Z, Yang J, Chen X, Liu Y. Intranasal morphology transformation nanomedicines for long-term intervention of allergic rhinitis. ACS Nano. 2023;17:25322\u201334.","journal-title":"ACS Nano"},{"key":"4385_CR111","doi-asserted-by":"publisher","unstructured":"Zhu M, Wang Z, He Y, Zhang B, Wu L, Liu C, Fei Y, Gao P, Cai J, Zuo X. Acidic tumor microenvironment-modulated nanoparticle potentiates gastric cancer photoimmunotherapy. J Adv Res. 2025;81:731\u201344. https:\/\/doi.org\/10.1016\/j.jare.2025.06.008.","DOI":"10.1016\/j.jare.2025.06.008"},{"key":"4385_CR112","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mattod.2024.04.001","volume":"75","author":"C Zhang","year":"2024","unstructured":"Zhang C, Han Z-Y, Chen K-W, Wang Y-Z, Yan X, Zhang X-Z. Polydopamine-armed microalgal oxygenerator targeting the hypoxia-adenosine axis to boost cancer photothermal immunotherapy. Mater Today. 2024;75:71\u201384.","journal-title":"Mater Today"},{"key":"4385_CR113","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1038\/s41467-025-57533-y","volume":"16","author":"L Zhu","year":"2025","unstructured":"Zhu L, Song G, Zhang W, Wu Y, Chen Y, Song J, Wang D, Li G, Tang BZ, Li Y. Aggregation induced emission luminogen bacteria hybrid bionic robot for multimodal phototheranostics and immunotherapy. Nat Commun. 2025;16:2578.","journal-title":"Nat Commun"},{"key":"4385_CR114","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/smll.201202090","volume":"9","author":"N Gandra","year":"2013","unstructured":"Gandra N, Abbineni G, Qu X, Huai Y, Wang L, Mao C. Bacteriophage bionanowire as a carrier for both cancer-targeting peptides and photosensitizers and its use in selective cancer cell killing by photodynamic therapy. Small. 2013;9:215\u201321.","journal-title":"Small"},{"key":"4385_CR115","doi-asserted-by":"publisher","first-page":"e2207198","DOI":"10.1002\/adma.202207198","volume":"35","author":"X Zhu","year":"2023","unstructured":"Zhu X, Chen S, Hu X, Zhao L, Wang Y, Huang J, Chen J, Qiu Y, Zhang X, Wang M, et al. Near-Infrared Nano-Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria. Adv Mater. 2023;35:e2207198.","journal-title":"Adv Mater"},{"key":"4385_CR116","doi-asserted-by":"publisher","first-page":"1910176","DOI":"10.1002\/adfm.201910176","volume":"30","author":"L Liu","year":"2020","unstructured":"Liu L, He H, Luo Z, Zhou H, Liang R, Pan H, Ma Y, Cai L. In Situ Photocatalyzed Oxygen Generation with Photosynthetic Bacteria to Enable Robust Immunogenic Photodynamic Therapy in Triple-Negative Breast Cancer. Adv Funct Mater. 2020;30:1910176.","journal-title":"Adv Funct Mater"},{"key":"4385_CR117","first-page":"199","volume":"5","author":"F Liang","year":"2024","unstructured":"Liang F, An X, Wang R, Wu W, Yang L, Zheng Y, et al. Microalgae-based drug delivery system for tumor microenvironment photo-modulating and synergistic chemo-photodynamic therapy of osteosarcoma. Eng Regen. 2024;5:199\u2013209.","journal-title":"Eng Regen"},{"key":"4385_CR118","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41420-024-02236-4","volume":"10","author":"G Li","year":"2024","unstructured":"Li G, Wang C, Jin B, Sun T, Sun K, Wang S, Fan Z. Advances in smart nanotechnology-supported photodynamic therapy for cancer. Cell Death Discov. 2024;10:466.","journal-title":"Cell Death Discov"},{"key":"4385_CR119","doi-asserted-by":"publisher","first-page":"e202310158","DOI":"10.1002\/anie.202310158","volume":"62","author":"W Lin","year":"2023","unstructured":"Lin W, Liu Y, Wang J, Zhao Z, Lu K, Meng H, Luoliu R, He X, Shen J, Mao ZW, Xia W. Engineered Bacteria Labeled with Iridium(III) Photosensitizers for Enhanced Photodynamic Immunotherapy of Solid Tumors. Angew Chem Int Ed Engl. 2023;62:e202310158.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4385_CR120","doi-asserted-by":"publisher","first-page":"e202414347","DOI":"10.1002\/anie.202414347","volume":"64","author":"K Jin","year":"2025","unstructured":"Jin K, Yu L, Zhang Y, Niu L, Huang Y, Zhang Y, Wu Y. A Microrobotic System Based on Engineered Bacteria for Targeted Self-Driven Photodynamic Therapy. Angew Chem Int Ed Engl. 2025;64:e202414347.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4385_CR121","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msac164","author":"J Kawaguchi","year":"2022","unstructured":"Kawaguchi J, Mori H, Iwai N, Wachi M. A secondary metabolic enzyme functioned as an evolutionary seed of a primary metabolic enzyme. Mol Biol Evol. 2022. https:\/\/doi.org\/10.1093\/molbev\/msac164.","journal-title":"Mol Biol Evol"},{"key":"4385_CR122","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1038\/s41467-022-33837-1","volume":"13","author":"G He","year":"2022","unstructured":"He G, Li Y, Younis MR, Fu LH, He T, Lei S, Lin J, Huang P. Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy. Nat Commun. 2022;13:6238.","journal-title":"Nat Commun"},{"key":"4385_CR123","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s43018-025-00932-3","volume":"6","author":"L Qiao","year":"2025","unstructured":"Qiao L, Niu L, Wang Z, Deng Z, Di D, Ma X, Zhou Y, Kong D, Wang Q, Yin J, et al. Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nat Cancer. 2025;6:612\u201328.","journal-title":"Nat Cancer"},{"key":"4385_CR124","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1073\/pnas.1715946115","volume":"115","author":"C Gregor","year":"2018","unstructured":"Gregor C, Gwosch KC, Sahl SJ, Hell SW. Strongly enhanced bacterial bioluminescence with the ilux operon for single-cell imaging. Proc Natl Acad Sci U S A. 2018;115:962\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4385_CR125","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1073\/pnas.1414558112","volume":"112","author":"CA Swofford","year":"2015","unstructured":"Swofford CA, Van Dessel N, Forbes NS. Quorum-sensing Salmonella selectively trigger protein expression within tumors. Proc Natl Acad Sci U S A. 2015;112:3457\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4385_CR126","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1039\/C6CS00616G","volume":"45","author":"W Fan","year":"2016","unstructured":"Fan W, Huang P, Chen X. Overcoming the Achilles\u2019 heel of photodynamic therapy. Chem Soc Rev. 2016;45:6488\u2013519.","journal-title":"Chem Soc Rev"},{"key":"4385_CR127","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.freeradbiomed.2021.11.019","volume":"179","author":"B Bortot","year":"2022","unstructured":"Bortot B, Apollonio M, Baj G, Andolfi L, Zupin L, Crovella S, di Giosia M, Cantelli A, Saporetti R, Ulfo L, et al. Advanced photodynamic therapy with an engineered M13 phage targeting EGFR: Mitochondrial localization and autophagy induction in ovarian cancer cell lines. Free Radic Biol Med. 2022;179:242\u201351.","journal-title":"Free Radic Biol Med"},{"key":"4385_CR128","doi-asserted-by":"publisher","first-page":"107053","DOI":"10.1016\/j.phrs.2023.107053","volume":"199","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang J, Huang Y, Wu J, Wang Y, Chen A, Guo Q, Zhang Y, Zhang S, Wang L, et al. An oncolytic system produces oxygen selectively in pancreatic tumor cells to alleviate hypoxia and improve immune activation. Pharmacol Res. 2024;199:107053.","journal-title":"Pharmacol Res"},{"key":"4385_CR129","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.addr.2014.10.020","volume":"81","author":"S Rachagani","year":"2015","unstructured":"Rachagani S, Macha MA, Heimann N, Seshacharyulu P, Haridas D, Chugh S, Batra SK. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Adv Drug Deliv Rev. 2015;81:16\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"4385_CR130","doi-asserted-by":"publisher","first-page":"103404","DOI":"10.1016\/j.redox.2024.103404","volume":"77","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Buc Calderon P. Targeting catalase in cancer. Redox Biol. 2024;77:103404.","journal-title":"Redox Biol"},{"key":"4385_CR131","doi-asserted-by":"publisher","first-page":"216363","DOI":"10.1016\/j.canlet.2023.216363","volume":"572","author":"K Shimizu","year":"2023","unstructured":"Shimizu K, Kahramanian A, Jabbar M, Turna Demir F, Gokyer D, Uthamacumaran A, Rajan A, Saad MA, Gorham J, Wakimoto H, et al. Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies. Cancer Lett. 2023;572:216363.","journal-title":"Cancer Lett"},{"key":"4385_CR132","doi-asserted-by":"publisher","first-page":"e2403866","DOI":"10.1002\/adhm.202403866","volume":"14","author":"S Jiang","year":"2025","unstructured":"Jiang S, Hao B, Song X, Jiang Y, Guo J, Wang Y, Wang Q, Wang X, Xu T, Wu X, et al. Living Microalgae-Based Magnetic Microrobots for Calcium Overload and Photodynamic Synergetic Cancer Therapy. Adv Healthc Mater. 2025;14:e2403866.","journal-title":"Adv Healthc Mater"},{"key":"4385_CR133","doi-asserted-by":"publisher","first-page":"114696","DOI":"10.1016\/j.addr.2023.114696","volume":"193","author":"Y Chen","year":"2023","unstructured":"Chen Y, Li Z-H, Zeng X, Zhang X-Z. Bacteria-based bioactive materials for cancer imaging and therapy. Adv Drug Deliv Rev. 2023;193:114696.","journal-title":"Adv Drug Deliv Rev"},{"key":"4385_CR134","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.apsb.2023.11.007","volume":"14","author":"L Yu","year":"2024","unstructured":"Yu L, Liu Z, Xu W, Jin K, Liu J, Zhu X, et al. Towards overcoming obstacles of type II photodynamic therapy: endogenous production of light, photosensitizer, and oxygen. Acta Pharm Sin B. 2024;14:1111\u201331.","journal-title":"Acta Pharm Sin B"},{"key":"4385_CR135","doi-asserted-by":"publisher","DOI":"10.1039\/D1CS01079D","author":"M Li","year":"2025","unstructured":"Li M, Xiong J, Zhang Y, Yu L, Yue L, Yoon C, et al. New guidelines and definitions for type I photodynamic therapy. Chem Soc Rev. 2025. https:\/\/doi.org\/10.1039\/D1CS01079D.","journal-title":"Chem Soc Rev"},{"key":"4385_CR136","doi-asserted-by":"publisher","first-page":"2316092","DOI":"10.1002\/adfm.202316092","volume":"34","author":"C Wang","year":"2024","unstructured":"Wang C, Chen L, Zhu J, Wang C, Li M, Miao Y, Liu N, Ji Z, Pan F, Liu Y. Programmable bacteria-based biohybrids as living biotherapeutics for enhanced cancer sonodynamic\u2010immunotherapy. Adv Funct Mater. 2024;34:2316092.","journal-title":"Adv Funct Mater"},{"key":"4385_CR137","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12951-025-03625-2","volume":"23","author":"M Cai","year":"2025","unstructured":"Cai M, Yang Y, Kong J, Zhang Y, Li S, Zhang H, Xv X, Ni J, Yin X. Nanoscale metal-organic frameworks as a versatile platform for synergistic combination tumor therapy. J Nanobiotechnol. 2025;23:601.","journal-title":"J Nanobiotechnol"},{"key":"4385_CR138","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1039\/D4SC08685F","volume":"16","author":"Y Ren","year":"2025","unstructured":"Ren Y, Zhang X, Li L, Yuan Q, Bao B, Li M, Tang Y. Donor modulation brings all-in-one phototheranostics for NIR-II imaging-guided type-I photodynamic\/photothermal synergistic cancer therapy. Chem Sci. 2025;16:5089\u201398.","journal-title":"Chem Sci"},{"key":"4385_CR139","doi-asserted-by":"publisher","first-page":"135994","DOI":"10.1016\/j.cej.2022.135994","volume":"442","author":"H Liu","year":"2022","unstructured":"Liu H, Zhang J, Jia Y, Liu X, Chen X, Zhao W, Mao C. Theranostic nanomotors for tumor multimode imaging and photothermal\/photodynamic synergistic therapy. Chem Eng J. 2022;442:135994.","journal-title":"Chem Eng J"},{"key":"4385_CR140","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.2147\/IJN.S503977","volume":"20","author":"V Visetvichaporn","year":"2025","unstructured":"Visetvichaporn V, Yu NY, Kang SW, Nguyen DT, Lim JP, Jang HS, et al. Synthesis of mesoporous polydopamine-coated upconversion nanoparticles for dual-enhanced photodynamic and photothermal cancer therapy. Int J Nanomed. 2025;20:2505\u201319.","journal-title":"Int J Nanomed"},{"key":"4385_CR141","doi-asserted-by":"publisher","first-page":"e1803474","DOI":"10.1002\/adma.201803474","volume":"31","author":"AH All","year":"2019","unstructured":"All AH, Zeng X, Teh DBL, Yi Z, Prasad A, Ishizuka T, Thakor N, Hiromu Y, Liu X. Expanding the Toolbox of Upconversion Nanoparticles for In Vivo Optogenetics and Neuromodulation. Adv Mater. 2019;31:e1803474.","journal-title":"Adv Mater"},{"key":"4385_CR142","doi-asserted-by":"publisher","first-page":"eadk9485","DOI":"10.1126\/sciadv.adk9485","volume":"10","author":"M Chen","year":"2024","unstructured":"Chen M, Han Q, Zhang M, Liu Y, Wang L, Yang F, Li Q, Cao Z, Fan C, Liu J. Upconversion dual-photosensitizer-expressing bacteria for near-infrared monochromatically excitable synergistic phototherapy. Sci Adv. 2024;10:eadk9485.","journal-title":"Sci Adv"},{"key":"4385_CR143","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1039\/D3MH00249G","volume":"10","author":"P Song","year":"2023","unstructured":"Song P, Han X, Li X, Cong Y, Wu Y, Yan J, Wang Y, Wang X, Mu Z, Wang L, et al. Bacteria engineered with intracellular and extracellular nanomaterials for hierarchical modulation of antitumor immune responses. Mater Horiz. 2023;10:2927\u201335.","journal-title":"Mater Horiz"},{"key":"4385_CR144","doi-asserted-by":"publisher","first-page":"102191","DOI":"10.1016\/j.xcrm.2025.102191","volume":"6","author":"H Wang","year":"2025","unstructured":"Wang H, Zheng L, Yang C, Jia L, Zhou R, Liu H, Dong Y, Xu X, Shi G, Yang J, et al. Probiotic-mediated tumor microenvironment reprogramming with protease-sensitive interleukin-15 and photothermal therapy. Cell Rep Med. 2025;6:102191.","journal-title":"Cell Rep Med"},{"key":"4385_CR145","doi-asserted-by":"publisher","first-page":"e2106669","DOI":"10.1002\/adma.202106669","volume":"34","author":"L Wang","year":"2022","unstructured":"Wang L, Cao Z, Zhang M, Lin S, Liu J. Spatiotemporally Controllable Distribution of Combination Therapeutics in Solid Tumors by Dually Modified Bacteria. Adv Mater. 2022;34:e2106669.","journal-title":"Adv Mater"},{"key":"4385_CR146","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004104","author":"JA Hangasky","year":"2022","unstructured":"Hangasky JA, Chen W, Dubois SP, Daenthanasanmak A, M\u00fcller JR, Reid R, et al. A very long-acting IL-15: implications for the immunotherapy of cancer. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-004104.","journal-title":"J Immunother Cancer"},{"key":"4385_CR147","doi-asserted-by":"publisher","first-page":"102573","DOI":"10.1016\/j.nano.2022.102573","volume":"44","author":"CI Nkanga","year":"2022","unstructured":"Nkanga CI, Ortega-Rivera OA, Steinmetz NF. Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coat. Nanomedicine. 2022;44:102573.","journal-title":"Nanomedicine"},{"key":"4385_CR148","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/cac2.70024","volume":"45","author":"X Han","year":"2025","unstructured":"Han X, Cheng Y, Wan D, Alu A, Zhang Z, Bi Z, Wang M, Tang Y, Hong W, Chen S, et al. Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL-1\u03b2 and the inflammasome pathway. Cancer Commun (Lond). 2025;45:794\u2013812.","journal-title":"Cancer Commun (Lond)"},{"key":"4385_CR149","doi-asserted-by":"publisher","first-page":"e2400702","DOI":"10.1002\/advs.202400702","volume":"11","author":"X Li","year":"2024","unstructured":"Li X, Liu Y, Gui J, Gan L, Xue J. Cell Identity and Spatial Distribution of PD-1\/PD-L1 Blockade Responders. Adv Sci (Weinh). 2024;11:e2400702.","journal-title":"Adv Sci (Weinh)"},{"key":"4385_CR150","doi-asserted-by":"publisher","first-page":"156888","DOI":"10.1016\/j.cyto.2025.156888","volume":"189","author":"S Safaei","year":"2025","unstructured":"Safaei S, Yari A, Pourbagherian O, Maleki LA. The role of cytokines in shaping the future of Cancer immunotherapy. Cytokine. 2025;189:156888.","journal-title":"Cytokine"},{"key":"4385_CR151","doi-asserted-by":"publisher","first-page":"102003","DOI":"10.1016\/j.nantod.2023.102003","volume":"53","author":"X Zhi","year":"2023","unstructured":"Zhi X, Yang P, Xu Y, Dai Z, Yue X, Qian L. Toll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy. Nano Today. 2023;53:102003.","journal-title":"Nano Today"},{"key":"4385_CR152","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2019.04.018","volume":"456","author":"A Teufel","year":"2019","unstructured":"Teufel A, Zhan T, H\u00e4rtel N, Bornschein J, Ebert MP, Schulte N. Management of immune related adverse events induced by immune checkpoint inhibition. Cancer Lett. 2019;456:80\u20137.","journal-title":"Cancer Lett"},{"key":"4385_CR153","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/CIRCULATIONAHA.121.056730","volume":"146","author":"H Zhu","year":"2022","unstructured":"Zhu H, Galdos FX, Lee D, Waliany S, Huang YV, Ryan J, Dang K, Neal JW, Wakelee HA, Reddy SA. Identification of pathogenic immune cell subsets associated with checkpoint inhibitor\u2013induced myocarditis. Circulation. 2022;146:316\u201335.","journal-title":"Circulation"},{"key":"4385_CR154","doi-asserted-by":"publisher","unstructured":"Sun Y, Liu Y, Ma X, Hu H. The influence of cell cycle regulation on chemotherapy. Int J Mol Sci. 2021;22:6923. https:\/\/doi.org\/10.3390\/ijms22136923.","DOI":"10.3390\/ijms22136923"},{"key":"4385_CR155","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1039\/D3CS00585B","volume":"54","author":"J Yuan","year":"2025","unstructured":"Yuan J, Yang H, Huang W, Liu S, Zhang H, Zhang X, Peng X. Design strategies and applications of cyanine dyes in phototherapy. Chem Soc Rev. 2025;54:341\u201366.","journal-title":"Chem Soc Rev"},{"key":"4385_CR156","doi-asserted-by":"publisher","first-page":"122771","DOI":"10.1016\/j.biomaterials.2024.122771","volume":"313","author":"L Zhang","year":"2025","unstructured":"Zhang L, Yu Y, Ding K, Ji C, Zhang D, Liang P, Tang BZ, Feng G. Tumor microenvironment ameliorative and adaptive nanoparticles with photothermal-to-photodynamic switch for cancer phototherapy. Biomaterials. 2025;313:122771.","journal-title":"Biomaterials"},{"key":"4385_CR157","doi-asserted-by":"publisher","first-page":"115846","DOI":"10.1016\/j.biopha.2023.115846","volume":"169","author":"Y Lu","year":"2023","unstructured":"Lu Y, Chen L, Wu Z, Zhou P, Dai J, Li J, Wen Q, Fan Y, Zeng F, Chen Y, Fu S. Self-driven bioactive hybrids co-deliver doxorubicin and indocyanine green nanoparticles for chemo\/photothermal therapy of breast cancer. Biomed Pharmacother. 2023;169:115846.","journal-title":"Biomed Pharmacother"},{"key":"4385_CR158","doi-asserted-by":"publisher","first-page":"108873","DOI":"10.1016\/j.bioorg.2025.108873","volume":"164","author":"ZE Eldin","year":"2025","unstructured":"Eldin ZE, Abou El-Reash YG, Al-Farraj ES, Ismail AM, El-Tohamy HM, Abdelbased KM, Al-Theyab NS, Elbeltagi S. Phage-coated vinorelbine-loaded hexagonal boron nitride for targeted lung cancer therapy via chemo-photothermal treatment. Bioorg Chem. 2025;164:108873.","journal-title":"Bioorg Chem"},{"key":"4385_CR159","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1039\/D2CS00102K","volume":"51","author":"S Son","year":"2022","unstructured":"Son S, Kim J, Kim J, Kim B, Lee J, Kim Y, Li M, Kang H, Kim JS. Cancer therapeutics based on diverse energy sources. Chem Soc Rev. 2022;51:8201\u201315.","journal-title":"Chem Soc Rev"},{"key":"4385_CR160","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12951-025-03599-1","volume":"23","author":"T Jiang","year":"2025","unstructured":"Jiang T, Tang Z, Tian S, Tang H, Jia Z, Li F, Qiu C, Deng L, Ke L, He P, et al. Metal-organic nanostructures based on sono\/chemo-nanodynamic synergy of Ti(x)O(y)\/Ru reaction units: for ultrasound-induced dynamic cancer therapy. J Nanobiotechnol. 2025;23:533.","journal-title":"J Nanobiotechnol"},{"key":"4385_CR161","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.actbio.2022.05.016","volume":"146","author":"W Li","year":"2022","unstructured":"Li W, Zhang Z, Liu J, Wang B, Pu G, Li J, et al. Nanodrug-loaded Bifidobacterium bifidum conjugated with anti-death receptor antibody for tumor-targeted photodynamic and sonodynamic synergistic therapy. Acta Biomater. 2022;146:341\u201356.","journal-title":"Acta Biomater"},{"key":"4385_CR162","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.actbio.2024.12.047","volume":"193","author":"C Xu","year":"2025","unstructured":"Xu C, Dong J, Shi X, Rui J, Chen M, Lu W, Zhang A, Wang S, Teng Z, Ye X. Engineered microalgae for photo-sonodynamic synergistic therapy in breast cancer treatment. Acta Biomater. 2025;193:531\u201344.","journal-title":"Acta Biomater"},{"key":"4385_CR163","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jcis.2024.05.175","volume":"671","author":"J Huang","year":"2024","unstructured":"Huang J, Ji L, Si J, Yang X, Luo Y, Zheng X, Ye L, Li Y, Wang S, Ge T, et al. Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer. J Colloid Interface Sci. 2024;671:216\u201331.","journal-title":"J Colloid Interface Sci"},{"key":"4385_CR164","doi-asserted-by":"publisher","first-page":"37447","DOI":"10.1021\/acsami.2c10028","volume":"14","author":"M Hosseini","year":"2022","unstructured":"Hosseini M, Ahmadi Z, Kefayat A, Molaabasi F, Ebrahimpour A, Naderi Khojasteh Far Y, et al. Multifunctional gold helix phototheranostic biohybrid that enables targeted image-guided photothermal therapy in breast cancer. ACS Appl Mater Interfaces. 2022;14:37447\u201365.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4385_CR165","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.7150\/thno.98257","volume":"14","author":"F Zeng","year":"2024","unstructured":"Zeng F, Du M, Yang Y, Fang J, Wang Y, Goh M, Lin Y, Wang H, Yan F, Chen Z. Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria. Theranostics. 2024;14:5945\u201364.","journal-title":"Theranostics"},{"key":"4385_CR166","doi-asserted-by":"publisher","first-page":"1910395","DOI":"10.1002\/adfm.201910395","volume":"30","author":"D Zhong","year":"2020","unstructured":"Zhong D, Li W, Qi Y, He J, Zhou M. Photosynthetic Biohybrid Nanoswimmers System to Alleviate Tumor Hypoxia for FL\/PA\/MR Imaging-Guided Enhanced Radio-Photodynamic Synergetic Therapy. Adv Funct Mater. 2020;30:1910395.","journal-title":"Adv Funct Mater"},{"key":"4385_CR167","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jconrel.2023.08.056","volume":"362","author":"H Luo","year":"2023","unstructured":"Luo H, Gao S. Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: from near-infrared-I to near-infrared-II. J Control Release. 2023;362:425\u201345.","journal-title":"J Control Release"},{"key":"4385_CR168","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1021\/cbmi.3c00009","volume":"1","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu Y, Chen L, Song J, Yang H. Optical and photoacoustic imaging in vivo: opportunities and challenges. Chem Biomed Imaging. 2023;1:99\u2013109.","journal-title":"Chem Biomed Imaging"},{"key":"4385_CR169","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature25021","volume":"553","author":"RW Bourdeau","year":"2018","unstructured":"Bourdeau RW, Lee-Gosselin A, Lakshmanan A, Farhadi A, Kumar SR, Nety SP, Shapiro MG. Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts. Nature. 2018;553:86\u201390.","journal-title":"Nature"},{"key":"4385_CR170","doi-asserted-by":"publisher","first-page":"216422","DOI":"10.1016\/j.ccr.2024.216422","volume":"528","author":"W-L Xia","year":"2025","unstructured":"Xia W-L, Ran X-Y, Xie K-P, Zhao Y, Chen J, Zhou Q, Yu X-Q, Li K. Optimized indocyanine green nanopreparations for biomedical applications. Coord Chem Rev. 2025;528:216422.","journal-title":"Coord Chem Rev"},{"key":"4385_CR171","doi-asserted-by":"publisher","first-page":"114004","DOI":"10.1016\/j.jconrel.2025.114004","volume":"385","author":"JE Park","year":"2025","unstructured":"Park JE, Kang SJ, Ahn JS, Choi SH, Lee JS, Kim JS, Park SH. Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models. J Control Release. 2025;385:114004.","journal-title":"J Control Release"},{"key":"4385_CR172","doi-asserted-by":"publisher","first-page":"102484","DOI":"10.1016\/j.mtbio.2025.102484","volume":"35","author":"L Yu","year":"2025","unstructured":"Yu L, Qiu Y, Liu B, Zhen X, Li R. Engineered nano-bacteria hybrids for precision cancer immunotherapy. Mater Today Bio. 2025;35:102484.","journal-title":"Mater Today Bio"},{"key":"4385_CR173","doi-asserted-by":"publisher","first-page":"113822","DOI":"10.1016\/j.jconrel.2025.113822","volume":"383","author":"N Ma","year":"2025","unstructured":"Ma N, Gao J, Pang X, Wu K, Yang S, Wei H, Hao Y. Formulation-optimized oncolytic viruses: Advancing systemic delivery and immune amplification. J Control Release. 2025;383:113822.","journal-title":"J Control Release"},{"key":"4385_CR174","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.ymthe.2025.03.035","volume":"33","author":"A Alwithenani","year":"2025","unstructured":"Alwithenani A, Hengswat P, Chiocca EA. Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation. Mol Ther. 2025;33:2217\u201328.","journal-title":"Mol Ther"},{"key":"4385_CR175","doi-asserted-by":"publisher","first-page":"e07820","DOI":"10.1002\/advs.202507820","volume":"12","author":"J Chen","year":"2025","unstructured":"Chen J, Chen J, Chen Y, Yuan W, Zhang J, Wang G, Dai Z. Engineering Bacteria as Living Therapeutics in Cancer Therapy. Adv Sci (Weinh). 2025;12:e07820.","journal-title":"Adv Sci (Weinh)"},{"key":"4385_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2025.104226","author":"X Geng","year":"2025","unstructured":"Geng X, Qu J, Yin X, Wang Q, Li W, Cui H, et al. Progress in therapeutic applications of microalgae and their bioactive compounds. Algal Res. 2025. https:\/\/doi.org\/10.1016\/j.algal.2025.104226.","journal-title":"Algal Res"},{"key":"4385_CR177","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout SZ, Miller DM, Emerick KS, Kaufman HL. Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol. 2023;20:160\u201377.","journal-title":"Nat Rev Clin Oncol"},{"key":"4385_CR178","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","volume":"28","author":"T Todo","year":"2022","unstructured":"Todo T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, Tanaka M. Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: a phase 2 trial. Nat Med. 2022;28:1630\u20139.","journal-title":"Nat Med"},{"key":"4385_CR179","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RH Andtbacka","year":"2015","unstructured":"Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, et al. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. J Clin Oncol. 2015;33:2780\u20138.","journal-title":"J Clin Oncol"},{"key":"4385_CR180","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/curroncol31020079","volume":"31","author":"S Lidagoster","year":"2024","unstructured":"Lidagoster S, Ben-David R, De Leon B, Sfakianos JP. BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer. Curr Oncol. 2024;31:1063\u201378.","journal-title":"Curr Oncol"},{"key":"4385_CR181","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002;20:142\u201352.","journal-title":"J Clin Oncol"},{"key":"4385_CR182","doi-asserted-by":"publisher","first-page":"1279387","DOI":"10.3389\/fimmu.2023.1279387","volume":"14","author":"KE Smith","year":"2023","unstructured":"Smith KE, Peng K-W, Pulido JS, Weisbrod AJ, Strand CA, Allred JB, Newsom AN, Zhang L, Packiriswamy N, Kottke T. A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: Safety, efficacy, and T cell responses. Front Immunol. 2023;14:1279387.","journal-title":"Front Immunol"},{"key":"4385_CR183","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.ymthe.2023.04.006","volume":"31","author":"J Heo","year":"2023","unstructured":"Heo J, Liang J-D, Kim CW, Woo HY, Shih I-L, Su T-H, et al. Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: phase I clinical trial. Mol Ther. 2023;31:2077\u201388.","journal-title":"Mol Ther"},{"key":"4385_CR184","doi-asserted-by":"publisher","first-page":"e2303907","DOI":"10.1002\/advs.202303907","volume":"11","author":"M Liu","year":"2024","unstructured":"Liu M, Zhang R, Huang H, Liu P, Zhao X, Wu H, He Y, Xu R, Qin X, Cheng Z, et al. Erythrocyte-Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects. Adv Sci (Weinh). 2024;11:e2303907.","journal-title":"Adv Sci (Weinh)"},{"key":"4385_CR185","first-page":"1","volume":"55","author":"Q Cheng","year":"2026","unstructured":"Cheng Q, Zhu Y, Lv S, Shi J, Kuang M, Wang L, et al. Engineered bacteria and bacteria-derived nanomaterials for cancer therapy: mechanisms, designs and advances. Bioact Mater. 2026;55:1\u201322.","journal-title":"Bioact Mater"},{"key":"4385_CR186","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrmicro.2017.172","volume":"16","author":"DT Riglar","year":"2018","unstructured":"Riglar DT, Silver PA. Engineering bacteria for diagnostic and therapeutic applications. Nat Rev Microbiol. 2018;16:214\u201325.","journal-title":"Nat Rev Microbiol"},{"key":"4385_CR187","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12951-024-02785-x","volume":"22","author":"X Yu","year":"2024","unstructured":"Yu X, Xu C, Sun J, Xu H, Huang H, Gan Z, George A, Ouyang S, Liu F. Recent developments in two-dimensional molybdenum disulfide-based multimodal cancer theranostics. J Nanobiotechnol. 2024;22:515.","journal-title":"J Nanobiotechnol"},{"key":"4385_CR188","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41573-025-01182-9","volume":"24","author":"M Beilmann","year":"2025","unstructured":"Beilmann M, Adkins K, Boonen HCM, Hewitt P, Hu W, Mader R, Moore S, Rana P, Steger-Hartmann T, Villenave R, van Vleet T. Application of new approach methodologies for nonclinical safety assessment of drug candidates. Nat Rev Drug Discov. 2025;24:705\u201325.","journal-title":"Nat Rev Drug Discov"},{"key":"4385_CR189","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.copbio.2020.02.016","volume":"65","author":"N Aggarwal","year":"2020","unstructured":"Aggarwal N, Breedon AME, Davis CM, Hwang IY, Chang MW. Engineering probiotics for therapeutic applications: recent examples and translational outlook. Curr Opin Biotechnol. 2020;65:171\u20139.","journal-title":"Curr Opin Biotechnol"},{"key":"4385_CR190","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1089\/104303400750038507","volume":"11","author":"R Wagner","year":"2000","unstructured":"Wagner R, Graf M, Bieler K, Wolf H, Grunwald T, Foley P, Uberla K. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther. 2000;11:2403\u201313.","journal-title":"Hum Gene Ther"},{"key":"4385_CR191","doi-asserted-by":"publisher","unstructured":"Niu L, Deng Z, Jin Y, Guan N, Ye H. Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives. Protein Cell. 2025:pwaf085. https:\/\/doi.org\/10.1093\/procel\/pwaf085.","DOI":"10.1093\/procel\/pwaf085"},{"key":"4385_CR192","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.7150\/thno.125301","volume":"16","author":"S Muhammad","year":"2026","unstructured":"Muhammad S, Li M, Jia Q, Ijaz M, Liang S, Zeng W, Chen D, Zhang Y, Du X, Song W, Guo B. Advances in the engineering of living probiotics for cancer immunotherapy. Theranostics. 2026;16:1164\u2013226.","journal-title":"Theranostics"},{"key":"4385_CR193","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.actbio.2021.02.006","volume":"124","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu X, Guo Y, Wang J, Zhang D, Mei Y, Shi J, Tan W, Zheng JH. Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics. Acta Biomater. 2021;124:72\u201387.","journal-title":"Acta Biomater"},{"key":"4385_CR194","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.molcel.2017.10.033","volume":"68","author":"F Stirling","year":"2017","unstructured":"Stirling F, Bitzan L, O\u2019Keefe S, Redfield E, Oliver JWK, Way J, Silver PA. Rational Design of Evolutionarily Stable Microbial Kill Switches. Mol Cell. 2017;68:686\u2013e697683.","journal-title":"Mol Cell"},{"key":"4385_CR195","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1038\/s41467-023-38651-x","volume":"14","author":"T Azad","year":"2023","unstructured":"Azad T, Rezaei R, Singaravelu R, Pelin A, Boulton S, Petryk J, Onsu KA, Martin NT, Hoskin V, Ghahremani M, et al. Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies. Nat Commun. 2023;14:3035.","journal-title":"Nat Commun"},{"key":"4385_CR196","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1038\/s41467-024-50843-7","volume":"15","author":"M Pigula","year":"2024","unstructured":"Pigula M, Lai YC, Koh M, Diercks CS, Rogers TF, Dik DA, Schultz PG. An unnatural amino acid dependent, conditional Pseudomonas vaccine prevents bacterial infection. Nat Commun. 2024;15:6766.","journal-title":"Nat Commun"},{"key":"4385_CR197","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/mt.2012.115","volume":"20","author":"O Hemminki","year":"2012","unstructured":"Hemminki O, Diaconu I, Cerullo V, Pesonen SK, Kanerva A, Joensuu T, Kairemo K, Laasonen L, Partanen K, Kangasniemi L, et al. Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer. Mol Ther. 2012;20:1821\u201330.","journal-title":"Mol Ther"},{"key":"4385_CR198","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/toxsci\/kfi316","volume":"88","author":"LA Diaz Jr","year":"2005","unstructured":"Diaz LA Jr., Cheong I, Foss CA, Zhang X, Peters BA, Agrawal N, Bettegowda C, Karim B, Liu G, Khan K, et al. Pharmacologic and toxicologic evaluation of C. novyi-NT spores. Toxicol Sci. 2005;88:562\u201375.","journal-title":"Toxicol Sci"},{"key":"4385_CR199","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.7150\/thno.87498","volume":"13","author":"Y Liang","year":"2023","unstructured":"Liang Y, Wang B, Chen Q, Fu X, Jiang C, Lin Z, Zhuang Q, Zeng Y, Liu X, Zhang D. Systemic delivery of glycosylated-PEG-masked oncolytic virus enhances targeting of antitumor immuno-virotherapy and modulates T and NK cell infiltration. Theranostics. 2023;13:5452\u201368.","journal-title":"Theranostics"},{"key":"4385_CR200","doi-asserted-by":"crossref","unstructured":"Samoranos KT, Krisiewicz AL, Karpinecz BC, Glover PA, Gale TV, Chehadeh C, Ashshan S, Koya R, Chung EY, Lim HL. pH Sensitive Erythrocyte-Derived Membrane for Acute Systemic Retention and Increased Infectivity of Coated Oncolytic Vaccinia Virus. Pharmaceutics 2022, 14.","DOI":"10.3390\/pharmaceutics14091810"},{"key":"4385_CR201","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41563-025-02270-2","volume":"24","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Lian X, Sun Y, Sung YC, Vaidya A, Chen Z, Gupta A, Chatterjee S, Zheng L, Guerrero E, et al. Publisher Correction: High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics. Nat Mater. 2025;24:1320.","journal-title":"Nat Mater"},{"key":"4385_CR202","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2016.07.004","volume":"237","author":"LA Rojas","year":"2016","unstructured":"Rojas LA, Condezo GN, Moreno R, Fajardo CA, Arias-Badia M, San Martin C, Alemany R. Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery. J Control Release. 2016;237:78\u201388.","journal-title":"J Control Release"},{"key":"4385_CR203","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","volume":"40","author":"T Harimoto","year":"2022","unstructured":"Harimoto T, Hahn J, Chen YY, Im J, Zhang J, Hou N, Li F, Coker C, Gray K, Harr N, et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat Biotechnol. 2022;40:1259\u201369.","journal-title":"Nat Biotechnol"},{"key":"4385_CR204","doi-asserted-by":"publisher","first-page":"11255","DOI":"10.1158\/0008-5472.CAN-05-2278","volume":"65","author":"H Kambara","year":"2005","unstructured":"Kambara H, Saeki Y, Chiocca EA. Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus. Cancer Res. 2005;65:11255\u20138.","journal-title":"Cancer Res"},{"key":"4385_CR205","first-page":"vdab184","volume":"4","author":"V Staedtke","year":"2022","unstructured":"Staedtke V, Gray-Bethke T, Liu G, Liapi E, Riggins GJ, Bai RY. Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor models. Neurooncol Adv. 2022;4:vdab184.","journal-title":"Neurooncol Adv"},{"key":"4385_CR206","doi-asserted-by":"publisher","first-page":"105094","DOI":"10.1016\/j.phrs.2020.105094","volume":"161","author":"A Osali","year":"2020","unstructured":"Osali A, Zhiani M, Ghaebi M, Meymanat M, Esmaeilzadeh A. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells. Pharmacol Res. 2020;161:105094.","journal-title":"Pharmacol Res"},{"key":"4385_CR207","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/php.13550","volume":"98","author":"L Finlayson","year":"2022","unstructured":"Finlayson L, Barnard IRM, McMillan L, Ibbotson SH, Brown CTA, Eadie E, et al. Depth penetration of light into skin as a function of wavelength from 200 to 1000 nm. Photochem Photobiol. 2022;98:974\u201381.","journal-title":"Photochem Photobiol"},{"key":"4385_CR208","doi-asserted-by":"publisher","first-page":"128630","DOI":"10.1016\/j.talanta.2025.128630","volume":"297","author":"M Zou","year":"2025","unstructured":"Zou M, Wang Y, Jiao J, Lv M, Mo T. Advances in the near-infrared \u2161 for in vivo fluorescence imaging applications: A review. Talanta. 2025;297:128630.","journal-title":"Talanta"},{"key":"4385_CR209","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.actbio.2025.03.046","volume":"197","author":"G Liu","year":"2025","unstructured":"Liu G, Wang H, Fei Z, Tao X, Zheng J, Cai G, Li X, Zhuang J, Ren H. Self-luminous nanoengineered bacteria with the sustained release of interleukin 2 as an in situ vaccine for enhanced cancer immunotherapy. Acta Biomater. 2025;197:386\u201399.","journal-title":"Acta Biomater"},{"key":"4385_CR210","doi-asserted-by":"publisher","first-page":"eadq5331","DOI":"10.1126\/scitranslmed.adq5331","volume":"17","author":"S Li","year":"2025","unstructured":"Li S, Chen S, Li Y, Sun W, Li J, Deng H, Ding H, Wang Z, Zhu L, Liu J, et al. Targeted suppression of glioma by ultralow-dose x-ray-induced photodynamic therapy and gold-based nanoclusters in preclinical models. Sci Transl Med. 2025;17:eadq5331.","journal-title":"Sci Transl Med"},{"key":"4385_CR211","doi-asserted-by":"publisher","first-page":"19691","DOI":"10.1021\/acsnano.2c07286","volume":"16","author":"L He","year":"2022","unstructured":"He L, Yu X, Li W. Recent progress and trends in X-ray-induced photodynamic therapy with low radiation doses. ACS Nano. 2022;16:19691\u2013721.","journal-title":"ACS Nano"},{"key":"4385_CR212","doi-asserted-by":"publisher","first-page":"17393","DOI":"10.1021\/acsnano.4c17421","volume":"19","author":"J Goo","year":"2025","unstructured":"Goo J, Lee JS, Park J, Jeon SI, Kim J, Yun WS, Shim N, Moon Y, Song S, Kim J, et al. Dual Delivery of Light\/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma Treatment. ACS Nano. 2025;19:17393\u2013409.","journal-title":"ACS Nano"},{"key":"4385_CR213","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1021\/acssynbio.1c00631","volume":"11","author":"B Lim","year":"2022","unstructured":"Lim B, Yin Y, Ye H, Cui Z, Papachristodoulou A, Huang WE. Reprogramming synthetic cells for targeted cancer therapy. ACS Synth Biol. 2022;11:1349\u201360.","journal-title":"ACS Synth Biol"},{"key":"4385_CR214","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1038\/sj.onc.1209045","volume":"24","author":"PK Working","year":"2005","unstructured":"Working PK, Lin A, Borellini F. Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses. Oncogene. 2005;24:7792\u2013801.","journal-title":"Oncogene"},{"key":"4385_CR215","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.smim.2025.101977","volume":"79","author":"D Thomas","year":"2025","unstructured":"Thomas D, Bharadwa P, Lee T, Ilkow CS. A framework for the rational design of oncolytic viruses: A holistic perspective considering the tumour microenvironment. Semin Immunol. 2025;79:101977.","journal-title":"Semin Immunol"},{"key":"4385_CR216","doi-asserted-by":"publisher","first-page":"122897","DOI":"10.1016\/j.lfs.2024.122897","volume":"352","author":"J Liu","year":"2024","unstructured":"Liu J, He C, Tan W, Zheng JH. Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives. Life Sci. 2024;352:122897.","journal-title":"Life Sci"},{"key":"4385_CR217","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1182\/blood-2024-211934","volume":"144","author":"V Grillo Alvarado","year":"2024","unstructured":"Grillo Alvarado V, Toumi R, Schutte A, Ruan A, Oda S. Engineering synergistic adoptive cell therapies for enhanced treatment of acute myeloid leukemia. Blood. 2024;144:3443\u20133443.","journal-title":"Blood"},{"key":"4385_CR218","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1182\/blood-2023-182705","volume":"142","author":"P Klener Jr","year":"2023","unstructured":"Klener P Jr., Daumov\u00e1 L, Kazantsev D, And\u011bra L, Petr\u00e1k J, Doln\u00edkov\u00e1 A, Bettazov\u00e1 N, Kova\u0159\u00edkov\u00e1 P, Rene\u0161ov\u00e1 N, Tu\u0161kov\u00e1 L, et al. biomarker Driven Strategies for Targeted Elimination of Hypoxia Adapted Lymphoma Cells. Blood. 2023;142:4374\u20134374.","journal-title":"Blood"},{"key":"4385_CR219","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1158\/2326-6066.CIR-23-0088","volume":"11","author":"J Wang","year":"2023","unstructured":"Wang J, Peng Z, Guo J, Wang Y, Wang S, Jiang H, Wang M, Xie Y, Li X, Hu M, et al. CXCL10 Recruitment of gammadelta T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression. Cancer Immunol Res. 2023;11:1384\u201399.","journal-title":"Cancer Immunol Res"},{"key":"4385_CR220","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.trecan.2025.08.009","volume":"11","author":"N Kwon","year":"2025","unstructured":"Kwon N, Chen YY. Overcoming solid-tumor barriers: armored CAR-T cell therapy. Trends Cancer. 2025;11:1019\u201329.","journal-title":"Trends Cancer"},{"key":"4385_CR221","doi-asserted-by":"publisher","unstructured":"Esapa B, Jiang J, Cheung A, Chenoweth A, Thurston DE, Karagiannis SN. Target antigen attributes and their contributions to clinically approved antibody-drug conjugates (ADCs) in haematopoietic and solid cancers. Cancers (Basel). 2023;15:1845. https:\/\/doi.org\/10.3390\/cancers15061845.","DOI":"10.3390\/cancers15061845"},{"key":"4385_CR222","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41392-020-0135-9","volume":"5","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu W, Wang L, Gao P, Li Z, Wu J, Zhang H, Wu H, Kong W, Yu B, Yu X. Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemia. Signal Transduct Target Ther. 2020;5:40.","journal-title":"Signal Transduct Target Ther"},{"key":"4385_CR223","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1182\/blood-2025-5912","volume":"146","author":"S Sendker","year":"2025","unstructured":"Sendker S, Yang S, Bader AC, Chen A, Bobilev E, Hu A, Deng X, Liu F, Hui V, Nguyen M, et al. Dual-function engineered bacteria remodel AML tumor microenvironment via IL-12 delivery and adenosine depletion to sustain NK cell immunity. Blood. 2025;146:5912\u20135912.","journal-title":"Blood"},{"key":"4385_CR224","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1182\/bloodadvances.2022008040","volume":"6","author":"AY Lin","year":"2022","unstructured":"Lin AY, Choi B, Sim T, Yang E, Choi H, Behdad A, Kim DH, Gordon LI. Enhanced systemic antilymphoma immune response by photothermal therapy with CpG deoxynucleotide-coated nanoparticles. Blood Adv. 2022;6:4581\u201392.","journal-title":"Blood Adv"},{"key":"4385_CR225","doi-asserted-by":"publisher","unstructured":"Liu Z, Liu X, Ma J, Zhang Y, Ye M, Liu H, Ding K, Song J, Fu R, Qi J. Harnessing targeted photodynamic therapy to synergistically activate T cell and NK cell responses in multiple myeloma. Adv Mater. 2025:e18663. https:\/\/doi.org\/10.1002\/adma.202518663.","DOI":"10.1002\/adma.202518663"},{"key":"4385_CR226","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1039\/D1CS00755F","volume":"51","author":"T Ci","year":"2022","unstructured":"Ci T, Zhang W, Qiao Y, Li H, Zang J, Li H, Feng N, Gu Z. Delivery strategies in treatments of leukemia. Chem Soc Rev. 2022;51:2121\u201344.","journal-title":"Chem Soc Rev"},{"key":"4385_CR227","doi-asserted-by":"publisher","first-page":"e09836","DOI":"10.1002\/advs.202509836","volume":"12","author":"Y Shi","year":"2025","unstructured":"Shi Y, Hou Y, Mabrouk MT, Yu C, Yang Y. In Situ Vaccines in the Era of Cancer Immunotherapy: Conceptual Innovation and Clinical Translation. Adv Sci (Weinh). 2025;12:e09836.","journal-title":"Adv Sci (Weinh)"},{"key":"4385_CR228","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1182\/blood-2024-211819","volume":"144","author":"MI Pereira","year":"2024","unstructured":"Pereira MI, Henriques IV, Amorim Machado P, Cortesao E, Sarmento-Ribeiro AB, Santos CG. A real-world analysis of the outcomes of septic shock in hematologic patients with acute myeloid leukemia. Blood. 2024;144:5988\u20135988.","journal-title":"Blood"},{"key":"4385_CR229","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.cmi.2022.03.032","volume":"28","author":"T Inkster","year":"2022","unstructured":"Inkster T, Peters C, Dancer S. Safe design and maintenance of bone marrow transplant units: a narrative review. Clin Microbiol Infect. 2022;28:1091\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"4385_CR230","doi-asserted-by":"publisher","first-page":"171582","DOI":"10.1016\/j.cej.2025.171582","volume":"527","author":"Y Xin","year":"2026","unstructured":"Xin Y, Yao J, Qiao W, Liu W, Hua X, Zheng X, Hui J, Fan D. Nanodynamic therapies for osteosarcoma: Recent advances and future perspectives. Chem Eng J. 2026;527:171582.","journal-title":"Chem Eng J"},{"key":"4385_CR231","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/pharmaceutics17101349","volume":"17","author":"G Zi","year":"2025","unstructured":"Zi G, Zhou W, Zhou L, Wang L, Zheng P, Wei S. Engineered Bacteria-Nano Hybrid System: The Intelligent Drug Factory for Next-Generation Cancer Immunotherapy. Pharmaceutics. 2025;17:1349.","journal-title":"Pharmaceutics"},{"key":"4385_CR232","doi-asserted-by":"publisher","first-page":"2401538","DOI":"10.1002\/adhm.202401538","volume":"13","author":"C Wang","year":"2024","unstructured":"Wang C, Feng Q, Shi S, Qin Y, Lu H, Zhang P, Liu J, Chen B. The rational engineered bacteria based biohybrid living system for tumor therapy. Adv Healthc Mater. 2024;13:2401538.","journal-title":"Adv Healthc Mater"},{"key":"4385_CR233","doi-asserted-by":"publisher","first-page":"105160","DOI":"10.1016\/j.neuint.2021.105160","volume":"150","author":"BB Garrido-Suarez","year":"2021","unstructured":"Garrido-Suarez BB, Garrido G, Bellma Menendez A, Merino N, Valdes O, Delgado-Hernandez R, Granados-Soto V. Synergistic interaction between amitriptyline and paracetamol in persistent and neuropathic pain models: An isobolografic analysis. Neurochem Int. 2021;150:105160.","journal-title":"Neurochem Int"},{"key":"4385_CR234","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1364\/BOE.393524","volume":"11","author":"T Sheng","year":"2020","unstructured":"Sheng T, Ong Y, Busch TM, Zhu TC. Reactive oxygen species explicit dosimetry to predict local tumor growth for Photofrin-mediated photodynamic therapy. Biomed Opt Express. 2020;11:4586\u2013601.","journal-title":"Biomed Opt Express"},{"key":"4385_CR235","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cell.2023.12.028","volume":"187","author":"T Kortemme","year":"2024","unstructured":"Kortemme T. De novo protein design\u2014from new structures to programmable functions. Cell. 2024;187:526\u201344.","journal-title":"Cell"},{"key":"4385_CR236","doi-asserted-by":"crossref","unstructured":"Cheng H-B, Cheng Y, Wang J, Liu H, Zhang K, Wu R, Li J, Fang Y, Hu R, Jeong H. Protein-based nanomedicines for cancer theranostics: From supramolecular self-assembly to AI-driven design and applications. Chem 2025.","DOI":"10.1016\/j.chempr.2025.102624"},{"key":"4385_CR237","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.cell.2023.01.035","volume":"186","author":"K Swanson","year":"2023","unstructured":"Swanson K, Wu E, Zhang A, Alizadeh AA, Zou J. From patterns to patients: advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell. 2023;186:1772\u201391.","journal-title":"Cell"},{"key":"4385_CR238","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41586-023-06369-x","volume":"620","author":"M Inda-Webb","year":"2023","unstructured":"Inda-Webb M, Jimenez M, Liu Q, Phan N, Ahn J, Steiger C, Wentworth A, Riaz A, Zirtiloglu T, Wong K. Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ. Nature. 2023;620:386\u201392.","journal-title":"Nature"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04385-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:02:51Z","timestamp":1781136171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04385-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":238,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4385"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04385-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"552"}}